Benefits
Supports the body's own nitric oxide production
S7's polyphenols are studied for helping the body make more of its own nitric oxide rather than supplying nitrates. In a 90-day trial, circulating stable NO (measured as nitrosylated hemoglobin) rose more in the S7 groups than placebo, supporting healthy NO status.
May support circulation through nitric oxide (blood flow not directly measured)
Nitric oxide acts as a vasodilator that signals blood vessels to relax. S7 raised a circulating nitric oxide marker versus placebo, but blood flow, blood pressure and the exercise 'pump' were never directly measured, so any circulation or pump benefit remains unproven.
Antioxidant support against everyday free radicals
The seven botanicals are rich in polyphenols and anthocyanins with antioxidant activity. In the human study, S7 was associated with lower mitochondrial reactive oxygen species generation, suggesting it helps the body manage oxidative stress.
Non-stimulant option for active adults
Because it works at a low milligram dose and is designed to raise the body's own nitric oxide, S7 is a caffeine-free, non-nitrate ingredient often stacked into pre-workouts and stimulant-free formulas. Workout blood flow and exercise performance were not measured in the available trials.
Mechanism of action
Upregulation of endogenous nitric oxide
Dietary polyphenols from the seven botanicals are thought to enhance the body's own NO output (via nitric oxide synthase pathways and preserved NO bioavailability) rather than acting as an exogenous nitrate donor. The trial tracked NO as nitrosylated hemoglobin (NOHb), a stable circulating reservoir.
Reduction of mitochondrial reactive oxygen species
Excess ROS scavenge and degrade NO. By lowering mitochondrial ROS generation, S7's antioxidant polyphenols may preserve NO from oxidative breakdown, indirectly increasing the amount of bioavailable nitric oxide.
Polyphenol and anthocyanin antioxidant activity
Green tea catechins, chlorogenic acids from green coffee, curcuminoids from turmeric, and anthocyanins from tart cherry and blueberry contribute overlapping free-radical-quenching and redox-signaling effects that underpin the blend's antioxidant profile.
Clinical trials
Randomized, double-blind, placebo-controlled study of S7 itself (Nemzer et al., 2021, Journal of Food Research 10(2):21). Note: this journal is not PubMed-indexed and several authors are affiliated with the manufacturer, so it has not been externally corroborated.
42 overweight or slightly obese adults assigned to placebo, 25 mg S7, or 50 mg S7 once daily for 90 days.
Circulating stable NO (NOHb) increased about 34% (25 mg) and 53% (50 mg) versus a small placebo rise, while mitochondrial ROS generation fell about 54% and 75% versus a slight placebo increase. Results are from a single small trial and should be viewed as preliminary.
Small double-blind, placebo-controlled, single-dose crossover pilot in 8 healthy adults, published as Nemzer et al., 2018, Free Radical Research 52(3):362-372 (PMID 29110555), where the authors label the test material 'S7 (SPECTRA7)'. Several authors are affiliated with the manufacturer (FutureCeuticals), and the design was dose-dependent, measuring nitric oxide only as an ex vivo blood marker.
8 healthy adults aged 24–55 given a single 50 mg dose of S7 versus placebo.
The study reported an increase in ex vivo bioavailable nitric oxide of up to about 2.3-fold, which is the source of the '230%' figure quoted throughout S7 marketing. With only 8 participants and nitric oxide measured as a blood marker rather than blood flow, blood pressure or exercise output, this is a preliminary signal, not a demonstrated benefit.
A single-dose, placebo-controlled human study of SPECTRA, a separate and larger FutureCeuticals polyphenol blend that is NOT the S7 product (Nemzer et al., 2014, Food Science & Nutrition 2(6):828-839, PMID 25493202, n=22). Included only as borrowed, different-formulation support for the botanical-polyphenol antioxidant and nitric oxide class.
22 healthy adults in a single-dose, placebo-controlled crossover measuring ex vivo reactive oxygen species and bioavailable nitric oxide markers.
The SPECTRA blend significantly lowered cellular and mitochondrial ROS and influenced NO/nitrosative markers, supporting the general concept that low-dose polyphenol blends can modulate oxidative stress and NO — but these data are on a different product, not S7.